PhaseBio Pharmaceuticals EV/Operating CF

EV/Operating CF of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Operating CF growth rates and interactive chart. A valuation metric that measures the enterprise value of a company compared to its operating cash flow. Operating cash flow (OCF) is the amount of cash generated by a company's normal business operations. It can be different from reported net income due to accrual accounting, that is expenses and revenues are recognized differently than cash is received. The cash going in and out of the business is what ultimately determines its financial health, so it's one of the most important metrics to watch. A low EV/OCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/OCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/Operating CF of PhaseBio Pharmaceuticals is -1.96 (as of December 31, 2021)
  • EV/Operating CF for the quarter ending March 31, 2022 was -0.87 (a -55.56% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Operating CF decreased by -66.31%
  • Annual EV/Operating CF for 2021 was -1.96 (a 43.96% increase from previous year)
  • Annual EV/Operating CF for 2020 was -1.36 (a -50.39% decrease from previous year)
  • Annual EV/Operating CF for 2019 was -2.74 (a -237.51% decrease from previous year)
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Operating CF of PhaseBio Pharmaceuticals

Most recent EV/Operating CFof PHAS including historical data for past 10 years.

Interactive Chart of EV/Operating CF of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals EV/Operating CF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.87
2021 -1.96 -2.65 -2.59 -1.96
2020 -0.92 -1.36
2019 -2.74 -1.41 -10.49 -11.17 -2.74
2018 2.0 1.03 2.0

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology